As well, intratumoral injection of either EGFR-CAR-NK-92 cells or oHSV-1 abrogated tumor development, while combination of EGFR-CAR NK-92 cells with oHSV-1 led to more effective elimination of MDA-MB-231 tumor cells compared to monotherapies in MDA-MB-231 cell bearing mice (128). The gene discussed is EGFR; the disease is neoplasm.